Moreover, kynurenine from tumor-repopulating T-cells (TRCs) have been reported to drive AhR dependent upregulation of programmed cell death protein 1 (PD-1) in CD8+ T cells, with potential consequences for cancer immunotherapies [299]. The gene discussed is AHR; the disease is cancer.